4.7 Article

Cellular adhesome screen identifies critical modulators of focal adhesion dynamics, cellular traction forces and cell migration behaviour

Journal

SCIENTIFIC REPORTS
Volume 6, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/srep31707

Keywords

-

Funding

  1. EU FP7 Health Programs MetaFight project [201862]
  2. Systems Microscopy NoE project [258068]
  3. the Netherlands Organization for Scientific Research NWO-FOM [09MMC03]

Ask authors/readers for more resources

Cancer cells migrate from the primary tumour into surrounding tissue in order to form metastasis. Cell migration is a highly complex process, which requires continuous remodelling and re-organization of the cytoskeleton and cell-matrix adhesions. Here, we aimed to identify genes controlling aspects of tumour cell migration, including the dynamic organization of cell-matrix adhesions and cellular traction forces. In a siRNA screen targeting most cell adhesion-related genes we identified 200+ genes that regulate size and/or dynamics of cell-matrix adhesions in MCF7 breast cancer cells. In a subsequent secondary screen, the 64 most effective genes were evaluated for growth factor-induced cell migration and validated by tertiary RNAi pool deconvolution experiments. Four validated hits showed significantly enlarged adhesions accompanied by reduced cell migration upon siRNA-mediated knockdown. Furthermore, loss of PPP1R12B, HIPK3 or RAC2 caused cells to exert higher traction forces, as determined by traction force microscopy with elastomeric micropillar post arrays, and led to considerably reduced force turnover. Altogether, we identified genes that co-regulate cell-matrix adhesion dynamics and traction force turnover, thereby modulating overall motility behaviour.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma

Pim Mutsaers, Hayri E. Balcioglu, Rowan Kuiper, Dora Hammerl, Rebecca Wijers, Mark van Duin, Bronno van der Holt, Annemiek Broijl, Walter Gregory, Sonja Zweegman, Pieter Sonneveld, Reno Debets

Summary: Multiple myeloma patients exhibit decreased T-cell immunity, with VISTA expression in the tumor microenvironment correlating significantly with patient survival and T-cell infiltration levels, suggesting VISTA as a potential target for immune therapies.

CANCERS (2021)

Article Oncology

Anti-PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8+ T cells

Maud Rijnders, Hayri E. Balcioglu, Debbie G. J. Robbrecht, Astrid A. M. Oostvogels, Rebecca Wijers, Maureen J. B. Aarts, Paul Hamberg, Geert J. L. H. van Leenders, J. Alberto Nakauma-Gonzalez, Jens Voortman, Hans M. Westgeest, Joost L. Boormans, Ronald de Wit, Martijn P. Lolkema, Astrid A. M. van der Veldt, Reno Debets

Summary: This study identified early changes in T-cell subsets that correlate with anti-PD-1 treatment response in patients with metastatic urothelial cancer (mUC). The decrease in the fraction of circulating PD-1(+) CD4(+) T cells and the juxtaposition of Th1 cells with CD8(+) and myeloid cells are associated with treatment response.

CLINICAL CANCER RESEARCH (2022)

Article Chemistry, Physical

Substrate rigidity modulates traction forces and stoichiometry of cell-matrix adhesions

Hayri E. Balcioglu, Rolf Harkes, Erik H. J. Danen, Thomas Schmidt

Summary: This study used quantitative super-resolution microscopy to investigate cell-matrix adhesions and found that there is a quantitative relationship between cellular traction force and the number of cell-matrix adhesion proteins. The stoichiometry of these proteins changes with different substrate stiffness, indicating a substrate-stiffness-dependent modulation of cell-matrix adhesion.

JOURNAL OF CHEMICAL PHYSICS (2022)

Article Oncology

Comparative single-cell RNA-sequencing profiling of BMP4-treated primary glioma cultures reveals therapeutic markers

Iris S. C. Verploegh, Andrea Conidi, Rutger W. W. Brouwer, Hayri E. Balcioglu, Panagiotis Karras, Samira Makhzami, Anne Korporaal, Jean-Christophe Marine, Martine Lamfers, Wilfred F. J. van IJcken, Sieger Leenstra, Danny Huylebroeck

Summary: This study characterized the cell viability of patient-derived GBM cultures in response to BMP4 and identified predictive markers for sensitivity to BMP4 using single-cell transcriptome profiling. The changes in composition of GBM cultures after BMP4 treatment correlated with treatment efficacy, with OLIG1/2 expression serving as a predictor and upregulation of RPL27A and RPS27 serving as useful early-response markers.

NEURO-ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

Cancer-Associated Mutations of the Adenosine A2A Receptor Have Diverse Influences on Ligand Binding and Receptor Functions

Chenlin Feng, Xuesong Wang, Willem Jespers, Rongfang Liu, Sofia Denise Zamarbide Losada, Marina Gorostiola Gonzalez, Gerard J. P. van Westen, Erik H. J. Danen, Laura H. Heitman

Summary: This study aims to explore the effects of cancer-patient-derived A(2A)AR mutations on ligand binding and receptor functions. The results show that 6 mutants decrease the binding affinity for agonist NECA, while the V275A mutant increases it. Mutations A165V and A265V also decrease the binding affinity for antagonist ZM241385.

MOLECULES (2022)

Review Biochemistry & Molecular Biology

Acute vs. chronic vs. intermittent hypoxia in breast Cancer: a review on its application in in vitro research

Qiuyu Liu, Victoria A. C. Palmgren, Erik H. J. Danen, Sylvia E. Le Devedec

Summary: Hypoxia is closely linked to therapeutic resistance in breast cancer and can induce an aggressive phenotype conducive to invasion and metastasis. However, there is currently no consensus on the duration of hypoxia and the presence of hypoxia-reoxygenation cycles. This review discusses current methods of hypoxia research, proposes a clear definition of acute, chronic, and intermittent hypoxia, and provides a foundation for in vitro (breast) cancer research related to hypoxia.

MOLECULAR BIOLOGY REPORTS (2022)

Review Genetics & Heredity

Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer

Yasmin Dekker, Sylvia E. Le Devedec, Erik H. J. Danen, Qiuyu Liu

Summary: This review studies the crosstalk between hypoxia and the extracellular matrix (ECM) in breast cancer. The findings suggest that hypoxia directly contributes to ECM remodeling, alters cell metabolism, and is regulated by the YAP/TAZ mechanotransduction pathway. The review highlights the importance of understanding these interactions for breast cancer progression.

GENES (2022)

Article Oncology

Intratumoral Niches of B Cells and Follicular Helper T Cells, and the Absence of Regulatory T Cells, Associate with Longer Survival in Early-Stage Oral Tongue Cancer Patients

Chumut Phanthunane, Rebecca Wijers, Maria J. De Herdt, Senada Koljenovic, Stefan Sleijfer, Robert J. Baatenburg de Jong, Jose Angelito U. Hardillo, Reno Debets, Hayri E. Balcioglu

Summary: In early oral squamous cell carcinoma patients, clusters between CD20 B cells and Tfh cells in the stromal invasive margin are positively associated with patient survival. The close relationship between follicular helper T cells and B cells is closely related to patient prognosis.

CANCERS (2022)

Article Biochemistry & Molecular Biology

GRHL2 Regulation of Growth/Motility Balance in Luminal versus Basal Breast Cancer

Zi Wang, Bircan Coban, Chen-Yi Liao, Yao-Jun Chen, Qiuyu Liu, Erik H. J. Danen

Summary: GRHL2 has different roles in different breast cancer subtypes, promoting cancer growth in some subtypes and suppressing cancer progression in others. Its expression is increased in all subtypes of breast cancer and inversely correlated with overall survival in basal-like breast cancer patients. GRHL2 regulates cell-cell junction, epithelial migration, and proliferation in both luminal and basal A breast cancer subtypes, but has distinct effects on cell cycle arrest and migration in these subtypes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Oncology

Prognostic Significance of Integrin Subunit Alpha 2 (ITGA2) and Role of Mechanical Cues in Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma (PDAC)

Alessandro Gregori, Cecilia Bergonzini, Mjriam Capula, Giulia Mantini, Fatemeh Khojasteh-Leylakoohi, Annalisa Comandatore, Ghazaleh Khalili-Tanha, Alireza Khooei, Luca Morelli, Amir Avan, Erik H. Danen, Thomas Schmidt, Elisa Giovannetti

Summary: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and chemoresistant cancer, with a stiff stroma surrounding it playing a role in chemoresistance. High expression of the mechanical sensor ITGA2 correlated with a poor prognosis in PDAC patients, and increased matrix stiffness led to the expression of ITGA2 and chemoresistance to gemcitabine. ITGA2 could be a potential therapeutic target to overcome gemcitabine resistance.

CANCERS (2023)

Article Oncology

Differential response of luminal and basal breast cancer cells to acute and chronic hypoxia

Qiuyu Liu, Nasi Liu, Vera van der Noord, Wanda van der Stel, Bob van de Water, Erik H. J. Danen, Sylvia E. Le Devedec

Summary: Hypoxia is associated with disease progression and poor prognosis in breast cancer, but little is known about the response of different breast cancer subtypes to hypoxia. This study compared the response of luminal and basal A subtype cell lines to acute and chronic hypoxia. The results showed that both subtypes activate HIF-related pathways, but basal A cells are less affected by hypoxia compared to luminal cells. Notably, hypoxia-induced gene networks were associated with worse survival in breast cancer patients. Different adaptation programs were observed in these subtypes, indicating their contribution to the progression of breast cancer.

BREAST CANCER RESEARCH AND TREATMENT (2023)

Article Oncology

Frequency of Peripheral CD8+T Cells Expressing Chemo-Attractant Receptors CCR1, 4 and 5 Increases in NPC Patients with EBV Clearance upon Radiotherapy

Shweta Mahajan, Hayri E. Balcioglu, Astrid Oostvogels, Willem A. Dik, K. C. Allen Chan, Kwok-Wai Lo, Edwin P. Hui, Anna Tsang, Joanna Tong, Wai Kei Jacky Lam, Kenneth Wong, Anthony T. C. Chan, Brigette B. Y. Ma, Reno Debets

Summary: Post-radiotherapy clearance of plasma EBV DNA is associated with prognosis in NPC patients. T cells, particularly CD8+ T cells expressing CCR1, 4 and/or 5, play a role in this clearance process. Differences in chemo-attractants related to T-cell chemotaxis are also linked to clinical outcome. Validation in larger cohorts is needed to confirm these findings.

CANCERS (2023)

Article Cell Biology

Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase

Pieter A. A. Roelofs, Mieke A. M. Timmermans, Bojana Stefanovska, Myrthe A. A. den Boestert, Amber W. M. van den Borne, Hayri E. E. Balcioglu, Anita M. M. Trapman, Reuben S. S. Harris, John W. M. Martens, Paul N. N. Span

Summary: APOBEC3B (A3B) is overexpressed in a subset of breast cancers and is associated with advanced disease, poor prognosis, and treatment resistance. The causes of A3B dysregulation in breast cancer remain unclear. In this study, A3B expression levels were quantified in cell lines and breast tumors and related to cell cycle markers. It was found that A3B expression is heterogeneous and strongly associated with the proliferation marker Cyclin B1. Dysregulated A3B overexpression in breast cancer is proposed to be the result of relief from repression and pathway activation during the G(2)/M phase of the cell cycle.

CELLS (2023)

Article Biochemistry & Molecular Biology

Hypoxia Triggers TAZ Phosphorylation in Basal A Triple Negative Breast Cancer Cells

Qiuyu Liu, Wanda van der Stel, Vera E. van der Noord, Hanneke Leegwater, Bircan Coban, Kim Elbertse, Joannes T. M. Pruijs, Olivier J. M. Bequignon, Gerard van Westen, Sylvia E. Le Devedec, Erik H. J. Danen

Summary: Hypoxia triggers HIF1 stabilization in luminal and basal A triple negative breast cancer cells. High throughput targeted RNA sequencing reveals overlapping and distinct target genes being modulated in these subtypes. Hypoxia induces phosphorylation of TAZ at Ser89 in basal A cells, leading to cytoplasmic sequestration of TAZ(Ser89). Hypoxia attenuates growth of basal A cells and diminishes the effect of verteporfin, a disruptor of YAP/TAZ-TEAD-mediated transcription.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

No Data Available